ATRC AtriCure
AtriCure earnings company data as of 4:00 PM ET 11/1
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 3 Nov | EPS | 0.01 | — | — |
| Rev | $151.2M | — | — |
Insider trades
Open-market buys and sales by ATRC's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $3.5M sold by 7 insiders outside a trading plan
- $880K sold by 1 insider under 10b5-1 plans
-
Salvatore Privitera Chief Technical OfficerPlanned sale$271K 4,519 shares at $60.00 3.1% of stakeTraded Sep 23 Filed Sep 24
-
Regina E Groves DirectorSale$288K 5,313 shares at $54.22 13% of stakeTraded Sep 11 Filed Sep 14
-
Salvatore Privitera Chief Technical OfficerPlanned sale$201K 3,657 shares at $55.00 2.4% of stakeTraded Sep 8 Filed Sep 10
-
Salvatore Privitera Chief Technical OfficerPlanned sale$408K 7,763 shares at $52.50 4.9% of stakeTraded Sep 2 Filed Sep 4
-
Karl S. Dahlquist Chief Legal OfficerSale$458K 9,370 shares at $48.89 9.7% of stakeTraded Aug 24 Filed Aug 26
-
Maggie Yuen DirectorSale$134K 3,500 shares at $38.42 20% of stakeTraded Aug 5 Filed Aug 7
-
Karen Prange DirectorSale$138K 3,564 shares at $38.80 14% of stakeTraded Aug 5 Filed Aug 7
-
Vinayak Doraiswamy Chief Scientific OfficerSale$233K 6,000 shares at $38.88 6.5% of stakeTraded Jul 28 Filed Jul 30
-
Justin J Noznesky Chief Mktg & Strategy OfficerSale$240K 6,182 shares at $38.80 5.8% of stakeTraded Jul 29 Filed Jul 30
-
Sven Wehrwein DirectorSale$946K 25,000 shares at $37.84 38% of stakeTraded Jul 28 Filed Jul 30
-
Karen Prange DirectorSale$86K 3,000 shares at $28.65 10% of stakeTraded May 20 Filed May 22
-
Vinayak Doraiswamy Chief Scientific OfficerSale$141K 5,000 shares at $28.13 5.2% of stakeTraded May 15 Filed May 18
-
Vinayak Doraiswamy Chief Scientific OfficerSale$149K 5,000 shares at $29.83 4.9% of stakeTraded Mar 12 Filed Mar 16
-
Justin J Noznesky Chief Mktg & Strategy OfficerSale$193K 5,166 shares at $37.29 6.2% of stakeTraded Nov 26, 2025 Filed Nov 26, 2025
-
Sven Wehrwein DirectorSale$377K 10,000 shares at $37.66 23% of stakeTraded Nov 24–25 Filed Nov 26, 2025
Also filed in the last 12 months, not counted as buying or selling: 28 stock grants, 7 share withholdings for taxes, 6 gifts, and 4 option exercises.
SEC filings
Recent issuer filings from EDGAR, 14 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 5.02,5.07,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K/A | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon
- Financial Intelligence, Revised Ed. View on Amazon